0001209191-21-002831.txt : 20210108
0001209191-21-002831.hdr.sgml : 20210108
20210108192846
ACCESSION NUMBER: 0001209191-21-002831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210106
FILED AS OF DATE: 20210108
DATE AS OF CHANGE: 20210108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stankovic Srdjan R.
CENTRAL INDEX KEY: 0001432545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 21518780
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-06
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001432545
Stankovic Srdjan R.
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
President
Common Stock
2021-01-06
4
M
0
5444
A
21972
D
Common Stock
2021-01-06
4
S
0
1725
53.34
D
20247
D
Common Stock
2021-01-07
4
M
0
61619
35.80
A
81866
D
Common Stock
2021-01-07
4
S
0
61619
55.1159
D
20247
D
Common Stock
2021-01-08
4
M
0
13381
35.80
A
33628
D
Common Stock
2021-01-08
4
M
0
12864
21.28
A
46492
D
Common Stock
2021-01-08
4
M
0
3488
18.12
A
49980
D
Common Stock
2021-01-08
4
S
0
29733
55.2192
D
20247
D
Restricted Stock Units
2021-01-06
4
M
0
5444
0.00
D
Common Stock
5444
16333
D
Stock Option (Right to Buy)
35.80
2021-01-06
4
M
0
61619
0.00
D
2027-09-06
Common Stock
61619
69631
D
Stock Option (Right to Buy)
35.80
2021-01-08
4
M
0
13381
0.00
D
2027-09-06
Common Stock
13381
56250
D
Stock Option (Right to Buy)
21.28
2021-01-08
4
M
0
12864
0.00
D
2028-10-14
Common Stock
12864
22761
D
Stock Option (Right to Buy)
18.12
2021-01-08
4
M
0
3488
0.00
D
2028-11-18
Common Stock
3488
90262
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units vest in four equal annual installments beginning January 6, 2021.
25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
25% of the shares subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
/s/ Austin D. Kim, Attorney-in-Fact
2021-01-08